The 2026 M&A Playbook for AI and Global Deals
The 2026 M&A landscape is experiencing a 15% surge in aggregate deal value driven by megadeals, even as small- and mid-cap markets remain sluggish. Artificial intelligence is fundamentally reshaping asset valuations and deal structures, forcing companies to adopt new acquisition and partnership strategies to secure a competitive edge. Concurrently, regional recoveries are advancing at varying speeds worldwide, heavily influenced by shifting geopolitical dynamics and stringent national security regulations.
Key facts
- Global M&A aggregate deal value increased by 15% year-over-year in early 2026, driven predominantly by megadeals despite a “missing middle” in smaller transactions
- The Boston Consulting Group (BCG) M&A Sentiment Index rose to 83, indicating cautious market improvement but remaining below the historical average of 100
- Regulatory scrutiny for mergers has shifted away from traditional antitrust concerns toward national security, industrial policy, and foreign subsidy reviews
- Strategic M&A accounts for only one-third of AI-related deals, with the remaining majority currently driven by financial investors
- Non-tech companies receive an average 0.8% announcement return from investors when executing strategic AI acquisitions
- Germany emerged as a standout global performer, experiencing increases in both deal value and volume led by industrials and healthcare megadeals
- The UK market saw transaction value double year-over-year, largely propelled by inbound mega-deals in finance and consumer goods
- Southeast Asian M&A deal value surged by 44%, though BCG notes the strategy remains underutilized relative to the region’s overall GDP
- The report’s econometric findings are based on a BCG database tracking over one million global deals since 1980
- The 2026 research was authored by a global team of BCG executives, led by Jens Kengelbach, Daniel Friedman, and CEO Christoph Schweizer
Takeaway
If you are planning to acquire a company this year, perhaps do not just slap an “AI” label on the deal and hope for the best—unless you truly enjoy overpaying for technology that will be completely obsolete by next Tuesday. Instead, carefully evaluate if you actually need to buy a shiny new tech startup or if you can just rent their software like the rest of us mere mortals. Furthermore, brace yourself for government regulators who suddenly care much more about national security than your corporate profit margins. Happy hunting, and remember: if all else fails in your strategy, you can always just pivot to healthcare megadeals in Germany.
Sources
Quiz: 10 questions
